menu
    • menu

    Company profile for Gangwal Healthcare

    Gangwal Healthcare-PSE
    News
    Gangwal Plot N-5 In Boisar, Palghar, India Receives Excipact GMP Certification

    31 Oct 2023

    // PRESS RELEASE

    The Nutrition Industry is Fast Catching Up with Pharma

    25 Jul 2022

    // ET HEALTH

    Gangwal Healthcare to set up unit for manufacturing nutraceuticals

    29 Jan 2022

    // THE HINDU

    DATA COMPILATION
    #PharmaFlow

    Gangwal Healthcare VB RM

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Booth #8.0Q2

    Book a meeting

    envelop Contact Supplier

    Latest Content

    https://www.youtube.com/embed/Lq2vvH6Z7J4

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    EXCIPIENTS

    Key Products KEY EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Related CompaniesRelated Companies

    About

    Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations!
    The building of a "best-in-class" solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gangwal Healthcareindia-flag Flag
    Country
    Country
    India
    Address
    Address
    705, Quantum Tower, Rambagh Lane, Behind State Bank Of India, Malad (west), Mu...
    Telephone
    Telephone
    +91 2241703000
    Client Email
    Email
    info@gangwalhealthcare.com
    Client Website
    Website
    https://gangwalhealthcare.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gangwal-healthcare-pvt-ltd
    youtube
    YouTube
    https://www.youtube.com/@gangwalhealthcare/videos
    Twitter
    Twitter
    https://x.com/GangwalLtd
    Contact Info
    Others

     

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI WW Frankfurt

    Booth #8.0Q2

    envelop Contact Supplier

    CPhI WW Frankfurt

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/gangwal-healthcare-party-content-65281.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/gangwal-healthcare-party-content-15934.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

    Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

    The pharmaceutical excipients market saw significant strategic consolidations, technological developments, and regulatory adaptations in 2025. Globally, the pharmaceutical excipients sector is growing at a compound annual growth rate of 6.6 percent, and was valued at US$ 8.85 billion in 2024. It is projected to reach US$ 14.77 billion by 2032.This year, the sector is witnessing technological advancements, regulatory evolution, and strategic business realignments. North America continues to dominate the global excipients landscape, with a 39.8 percent market share. The Asia-Pacific region is the fastest-growing segment with a substantial 30.4 percent market share, driven by increasing investments in pharmaceutical manufacturing, growing demand for cost-effective drugs, and rising healthcare expenditure across developing economies.Major excipient providers include BASF, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, DuPont, Evonik, Seqens, Actylis, SPI Pharma, PMC Isochem, Croda International, Pfanstiehl, Kewpie Corporation, Boai NKY Pharmaceuticals, ICE Pharma, Roquette, Nanjing Well Pharmaceutical, Minakem, Ashland Global, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)Roquette restructures after buying IFF Pharma; Colorcon partners ASHA CelluloseIn May, Roquette completed its acquisition of IFF Pharma Solutions. Valued at up to US$ 2.85 billion in enterprise value, this transaction represents a major consolidation in the pharmaceutical excipients market. The acquisition significantly enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide. Roquette announced a comprehensive, new organizational structure following the acquisition, indicating the company’s commitment to integrate IFF Pharma Solutions’ capabilities seamlessly into its existing operations. This consolidation creates a more robust platform for addressing the growing demand for specialized excipients in complex drug formulations, particularly as the industry moves towards more personalized approaches to medicines.So far, the year has also witnessed some strategic alliances, such as Colorcon’s partnership with ASHA Cellulose. As part of the deal, Colorcon will become the exclusive representative for two ASHA products — ASHACEL and ASHAKOTE — throughout Europe, the Middle East, Africa, Northeast Asia and Southeast Asia.Brenntag Specialties has announced an exclusive distribution agreement with MEGGLE Excipients to expand market reach. This collaboration makes available a broad portfolio of over 30 high-quality lactose-based excipients for various applications in the pharmaceutical industries across the Netherlands, Belgium, Norway, Finland, and Sweden.The portfolio’s versatility offers optimal solutions for a wide range of pharmaceutical applications, including tableting through both granulation and direct compression, powder preparations, and dry powder inhalation. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)WHO, FDA drive new standards with GMP guidelines; Pfanstiehl launches injectable-grade glycineIn March, the World Health Organization had put out a publication titled “Good Manufacturing Practices for Excipients used in Pharmaceutical Products.” WHO’s excipient GMP guideline emphasizes modern quality management principles, comprehensive risk assessment protocols, and supplier qualification procedures for excipients across all stages of production, storage, and distribution.Meanwhile, the US Food and Drug Administration (FDA) has proposed amendments to the Food, Drug, and Cosmetic Act as part of its FY 2025 legislative proposals, specifically targeting supply chain transparency for high-risk excipients. The FDA proposal would require certain excipients designated as high-risk to carry labeling that identifies the original manufacturer’s name and address. This initiative addresses what FDA has identified as a lack of transparency in excipient supply chains.In April, IFF Pharma Solutions launched Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC). This innovative product is specifically designed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages, addressing one of the most pressing concerns in contemporary pharmaceutical manufacturing.Pfanstiehl, a global leader in high-purity excipient manufacturing, announced the launch of its High Purity Low Endotoxin Low Metals (HPLE-LM) injectable-grade glycine. This multi-compendial glycine is specifically engineered for use in biologics, vaccines, and the downstream purification of monoclonal antibodies (mAbs). Manufactured under ICH-Q7 cGMP regulations at Pfanstiehl’s advanced facility in Waukegan, Illinois, the product meets stringent global pharmacopeial standards. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)Shin-Etsu Chemical invests in Japan, Germany to expand cellulose productionIn March, Shin-Etsu Chemical announced investments in pharmaceutical cellulose business operations in Japan and Europe, thereby showing significant commitment to market expansion. The company is making substantial investments at two key bases: the subsidiary SE Tylose GmbH in Germany, and the Naoetsu Plant in Joetsu, Japan. In Germany, a new production facility for the pharmaceutical excipient L-HPC will be built adjacent to the existing facility, creating a dual base with the Naoetsu Plant. The excipients market in 2025 has seen innovation in functional applications. Research on BENEO’s Palatinose as a bedtime drink shows that it improves aspects of sleep and represents an innovative approach to excipient functionality. Palatinose is a naturally sourced, smart carbohydrate that provides full carbohydrate energy in a more balanced way, thanks to its low-glycemic profile.Gangwal Healthcare, with its EXCiPACT-certified GMP facilities and a robust portfolio of co-processed excipients like ProBlend, Starlose, and Microlose, is actively contributing to the pharmaceutical industry’s demand for functional excipients. The company also offers cellulose-based excipients such as Solvostar (Sodium Starch Glycolate) and Sallyso (Croscarmellose Sodium), designed to improve tablet disintegration and drug release profiles in oral solid dosage forms.Evonik announced a partnership with South Korea–based CDMO ST Pharm to expand its RNA and nucleic acid delivery services. This collaboration enables Evonik to integrate customized nucleic acids from ST Pharm seamlessly with its lipid and lipid nanoparticle (LNP) development and fill-and-finish services. This streamlined approach means that pharmaceutical companies can reduce complexity and increase speed-to-market for nucleic acid therapeutics. View Our Dashboard on Major Excipient Companies in 2025 (Free Excel Available)Our viewThe pharmaceutical excipients market in 2025 is being shaped by several key trends including the development of multifunctional excipients that can simultaneously improve solubility, bioavailability, and control drug release in increasingly complex formulations.Moreover, the expanding generic medicines market is creating demand for cost-effective, versatile excipients. The growing importance of biologics and biosimilars is driving innovation in specialized excipients designed to maintain the stability and efficacy of these complex therapeutic products throughout their lifecycle. And nanotechnology continues to enable advanced nano-excipients for enhanced drug delivery and efficacy.In addition to these trends, we also notice a shift towards natural and plant-based excipients that is driven by sustainability concerns and potential biocompatibility benefits. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3650

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks

    #PharmaFlow by PHARMACOMPASS
    29 May 2025
    Share Share
    Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination

    Excipient Market Overview: Roquette, Seqens, Evonik make strategic moves; new guidelines deal with contamination

    The pharmaceutical industry has long recognized the critical role excipients or inactive ingredients play in drug formulation and delivery. Excipients can comprise up to 90 percent of a medicine's total ingredients and serve crucial functions as binders, disintegrants, coatings, preservatives, colors, and flavorings. According to recent market research, the pharmaceutical excipients market was valued at US$ 9.27 billion in 2023. It is growing at a compound annual growth rate (CAGR) of 7.03 percent and is projected to reach US$ 18.48 billion by 2032. The main factors driving market growth is an increased demand for multifunctional excipients, coupled with the expanding use of generic medications. The development in the biologics sector and advancements in nanotechnology are also contributing significantly to market growth. Major excipient providers include BASF, Evonik, Merck KGaA owned MilliporeSigma, Gangwal Healthcare, Roquette Frères, DuPont, Croda International, Seqens, Boai NKY Pharmaceuticals, PMC Isochem, Minakem, Kewpie Corporation, Ashland Global, SPI Pharma, Pfanstiehl, Nanjing Well Pharmaceutical, ICE Pharma, Anhui Ribobay Pharmaceutical and Nippon Fine Chemical.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available) WHO, India’s CDSCO tighten regulations; new GMP guidelines implemented to curb contamination Last year, the World Health Organization (WHO) issued a health alert linking at least 300 child deaths in the Gambia, Uzbekistan, and Indonesia to the ingestion of contaminated cough syrups containing unacceptable levels of diethylene glycol (DEG) and ethylene glycol (EG). In response to the tragic events, the WHO released two draft appendices to its guideline on good manufacturing practices (GMPs) for excipients this year. Manufacturers are now required to use suitable risk assessment tools to identify and mitigate potential hazards.  Since India-made cough syrups had been linked to the deaths, India’s drug regulator — Central Drugs Standard Control Organization (CDSCO) — took steps to prevent contamination, and advised drugmakers to only use pharmaceutical-grade excipients from approved sources. Furthermore, the Indian Health Ministry proposed amendments to the Drugs and Cosmetics Rules, 1945 to include details of excipients on drug labels. While listing all excipients on every strip of medicine may be challenging, the ministry suggested mentioning those causing hypersensitivity on the label. Applicants now mandatorily need to submit evidence of stability and safety of excipients. These regulatory developments have significant implications for excipient manufacturers and pharmaceutical companies worldwide. Leading pharmaceutical excipient firms like Gangwal Healthcare, Sigachi Industries, and Nitika Pharmaceuticals are well-positioned to meet these heightened quality and safety standards, given their long-standing commitment to producing high-quality, compliant excipients.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Roquette buys IFF’s pharma unit for US$ 2.85 bn; Evonik opens new spray-drying facility in Darmstadt In a significant industry move, France-based Roquette entered into an agreement to acquire IFF's pharma solutions business in a deal valued at US$ 2.85 billion. This acquisition is set to rebalance family-owned Roquette’s portfolio around health and nutrition. The deal is expected to accelerate Roquette’s growth and significantly strengthen its presence in the excipients market. Evonik has opened a new facility for drying aqueous dispersions of its Eudragit polymers at its site in Darmstadt, Germany. The facility will help Evonik meet increasing demand from drugmakers for its oral drug delivery solutions. The plant uses green energy solutions. The company has also partnered University of Mainz to commercialize a new class of polyethylene glycols (PEG) lipids for nucleic acid delivery. Evonik’s Health Care business has been growing its nucleic acid drug and vaccine delivery portfolio.  Germany’s Johannes Gutenberg University of Mainz was the first to develop randomized polyethylene glycols (rPEGs). This collaboration aims to expand Evonik’s toolbox of technologies for nucleic acid-based medicines, offering an improved immunogenicity profile for lipid nanoparticle carriers used in mRNA vaccines and therapeutics. Asahi Kasei made significant strides in addressing a pressing industry concern that emerged in 2018 when potentially carcinogenic nitrosamine impurities were detected in several pharmaceuticals. Guided by regional authorities, such as the European Medicines Agency and the US Food and Drug Administration, the pharmaceutical industry has been carrying out extensive assessments and research to identify the cause of these impurities. In response to this challenge, Asahi Kasei developed its Ceolus microcrystalline cellulose with extremely low nitrite levels. The Japanese company achieved nitrite concentrations of 0.1 micrograms per gram or less, which is equivalent to 0.1 parts per million (ppm). The company also started full commercial operation of its second manufacturing facility for Ceolus in Japan, enhancing supply capacity and stability. JRS Pharma and Gujarat Microwax opened a state-of-the-art cotton-based croscarmellose sodium plant in Mehsana, Gujarat (India). This facility aims to produce high-quality excipients that meet global standards, potentially reducing India's dependency on imports and boosting its presence in the global excipient market. The Indian excipient industry accounts for less than 1 percent of the global market share.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Seqens to advance innovative polymer; biologics, personalized medicine create demand for specialized excipients Recent industry collaborations highlight the ongoing innovation in novel excipients. France’s Seqens, with over 20 years of polymer development experience, was chosen by Pleryon Therapeutics to advance its leading osteoarthritis candidate – an innovative GMP polymer. This collaboration leverages Seqens’ newly expanded and modernized cGMP plant in Aramon, France, demonstrating the industry’s commitment to investing in advanced manufacturing capabilities for novel excipients.  The rise of biologics and personalized medicine has created a demand for specialized excipients capable of stabilizing complex molecules and enabling targeted drug delivery. Roquette’s launch of Lycagel Flex, a hydroxypropyl pemix for nutraceutical and pharmaceutical softgel capsules, exemplifies this trend. Built on Roquette’s market-first Lycagel pea starch technology, this plant-based alternative to gelatin offers manufacturers the flexibility to customize formulations for a range of production and end-user needs. The innovative pea starch foundation also underscores the industry’s move towards sustainable bio-based excipients. The trend towards patient-centric drug development has also influenced excipient innovation. Excipients that can improve palatability, ease of swallowing, or enable novel dosage forms (such as orally disintegrating tablets) are in high demand. For example, IFF brought a super disintegrant Ac-Di-Sol, that supports faster disintegration and drug dissolution in oral disintegrating tablets, improving patient experience.  View Our Dashboard on Major Excipient Companies in 2024 (Free Excel Available)   Our view The heightened regulatory scrutiny on excipients due to product contamination incidents has created a high risk perception and uncertainty around the regulatory acceptance of novel excipients. That said, novel excipients are central to the development of new drug modalities and therapies. Going forward, sustainability will also become an increasingly important factor in excipient selection and development. As the industry innovates towards biologics, personalized therapies, and patient-centric formulations, the role of high-quality, multifunctional excipients will only grow more vital in ensuring drug stability, bioavailability, and patient compliance. Companies that can navigate the complex regulatory landscape, invest in R&D, and offer high-quality, multifunctional excipients will be well-positioned to succeed in this evolving market.   
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3275

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination

    #PharmaFlow by PHARMACOMPASS
    12 Sep 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Gangwal Plot N-5 In Boisar, Palghar, India Receives Excipact GMP Certification
    Gangwal Plot N-5 In Boisar, Palghar, India Receives Excipact GMP Certification

    31 Oct 2023

    // PRESS RELEASE

    https://www.pharmacompass.com/pdf/news/gangwal-plot-n-5-in-boisar-palghar-india-receives-excipact-gmp-certification-93713.pdf

    PRESS RELEASE
    31 Oct 2023
    Share Share
    The Nutrition Industry is Fast Catching Up with Pharma
    The Nutrition Industry is Fast Catching Up with Pharma

    25 Jul 2022

    // ET HEALTH

    https://health.economictimes.indiatimes.com/news/industry/the-nutrition-industry-is-fast-catching-up-with-pharma-by-way-of-regulations-quality-and-clinical-trials-anil-jain-gangwal-healthcare/93042953

    ET HEALTH
    25 Jul 2022
    Share Share
    Gangwal Healthcare to set up unit for manufacturing nutraceuticals
    Gangwal Healthcare to set up unit for manufacturing nutraceuticals

    29 Jan 2022

    // THE HINDU

    https://www.thehindu.com/business/gangwal-healthcare-to-set-up-unit-for-manufacturing-nutraceuticals/article38346256.ece

    THE HINDU
    29 Jan 2022
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Salmeterol Xinafoate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #8.0Q2
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 26863

    Submission : 2013-02-04

    Status : Active

    Type : II

     CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Gangwal Healthcare CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Timolol Maleate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #8.0Q2
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
    USDMF CEP/COS JDMF EU-WCInactive-api
    ✖

    Date of Issue : 2022-08-07

    Valid Till : 2024-04-11

    Written Confirmation Number : WC-0432n

    Address of the Firm :

    NDC KDMF VMF Others AUDIT
    Gangwal Healthcare CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Formoterol Fumarate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #8.0Q2
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Gangwal Healthcare CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Modafinil

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #8.0Q2
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Gangwal Healthcare CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Palmitoylethanolamide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Booth #8.0Q2
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Gangwal Healthcare CB

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    LISTED APIs

    read-more
    read-more
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

      Formoterol Fumarate

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identi...
      Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.
      Gangwal Healthcare CB

      01

      Formoterol Fumarate

      India
      arrow
      CPhI WW Frankfurt
      Booth #8.0Q2
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

      Gangwal Healthcare

      Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.

      About the Company : Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understandin...

      Gangwal Healthcare CB

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

        Modafinil

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identi...
        Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.
        Gangwal Healthcare CB

        02

        Modafinil

        India
        arrow
        CPhI WW Frankfurt
        Booth #8.0Q2
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

        Gangwal Healthcare

        Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.

        About the Company : Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understandin...

        Gangwal Healthcare CB

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

          Palmitoylethanolamide

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identi...
          Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.
          Gangwal Healthcare CB

          03

          Palmitoylethanolamide

          India
          arrow
          CPhI WW Frankfurt
          Booth #8.0Q2
          • fda
          • EDQM
          • WHO-GMP
          Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

          Gangwal Healthcare

          Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.

          About the Company : Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understandin...

          Gangwal Healthcare CB

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Supplier
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

            Salmeterol Xinafoate

            Product
            Web Link

            Stock Recap
            #PipelineProspector

            Market
            Place

            Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identi...
            Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.
            Gangwal Healthcare CB

            04

            Salmeterol Xinafoate

            India
            arrow
            CPhI WW Frankfurt
            Booth #8.0Q2
            • fda
            • EDQM
            • WHO-GMP
            Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

            Gangwal Healthcare

            Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.

            About the Company : Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understandin...

            Gangwal Healthcare CB

            Product
            Web Link

            Stock Recap
            #Pipeline Prospector

            Market
            Place

            Contact Supplier
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Timolol Maleate

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identi...
              Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.
              Gangwal Healthcare CB

              05

              Timolol Maleate

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Gangwal Healthcare

              Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understanding the complexities of a customer's needs and identifying gaps. New technologies and Drug Delivery Systems are studied, and appropriate excipients are identified to resolve the problem. Working closely with our customers for over 35 years, Gangwal has made this possible due to a team of highly technical and marketing professionals with decades of experience in problem-solving.

              About the Company : Gangwal Healthcare – a solutions provider for Complex, Innovative & Cutting-edge technological formulations! The building of a 'best-in-class' solution provider starts with understandin...

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #Pipeline Prospector

              Market
              Place

              Only 10 entries up to this point, click to access all click full view read-more
              click full view
              Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

              FDF Dossiers

              read-more
              read-more

              01

              Brand Name : GranuMet-SR

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Regulatory Info : USP-NF • IP

              Registration Country : India

              Metformin HCl

              Gangwal Healthcare

              Dosage Form : PFI- SR Granules for Tab...

              Brand Name : GranuMet-SR

              Dosage Strength : 71.43%

              Packaging :

              Approval Date :

              Application Number :

              Regulatory Info : USP-NF • IP

              Registration Country : India

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              02

              Brand Name : GranuMet-SR

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Regulatory Info : USP-NF • IP

              Registration Country : India

              Metformin HCl

              Gangwal Healthcare

              Dosage Form : PFI- SR Granules for Tab...

              Brand Name : GranuMet-SR

              Dosage Strength : 74.62%

              Packaging :

              Approval Date :

              Application Number :

              Regulatory Info : USP-NF • IP

              Registration Country : India

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              03

              Brand Name : GranuMet-SR

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Regulatory Info : USP-NF • IP

              Registration Country : India

              Metformin HCl

              Gangwal Healthcare

              Dosage Form : PFI- SR Granules for Tab...

              Brand Name : GranuMet-SR

              Dosage Strength : 77.52%

              Packaging :

              Approval Date :

              Application Number :

              Regulatory Info : USP-NF • IP

              Registration Country : India

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              04

              Brand Name : Telmisartan Granules

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Regulatory Info : IP

              Registration Country : India

              Telmisartan

              Gangwal Healthcare

              Dosage Form : PFI- DC Granules for Tab...

              Brand Name : Telmisartan Granules

              Dosage Strength : 28.88%

              Packaging :

              Approval Date :

              Application Number :

              Regulatory Info : IP

              Registration Country : India

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              05

              Brand Name : Telmisartan Granules

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Regulatory Info : IP

              Registration Country : India

              Telmisartan

              Gangwal Healthcare

              Dosage Form : PFI- DC Granules for Tab...

              Brand Name : Telmisartan Granules

              Dosage Strength : 19.05%

              Packaging :

              Approval Date :

              Application Number :

              Regulatory Info : IP

              Registration Country : India

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              06

              Brand Name : Telmisartan Granules

              India
              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

              Regulatory Info : IP

              Registration Country : India

              Telmisartan

              Gangwal Healthcare

              Dosage Form : PFI- DC Granules for Tab...

              Brand Name : Telmisartan Granules

              Dosage Strength : 21%

              Packaging :

              Approval Date :

              Application Number :

              Regulatory Info : IP

              Registration Country : India

              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

              KEY PRODUCTS

              read-more
              read-more

              TOP RANKED SUPPLIER FOR:
              Sponsored Ads.full-view
              Sponsored Ads.full-view

              Services

              Discover the service capabilities from this company

              Drug Product Manufacturing

              Discover their expertise for : Drug Product Manufacturing

              Excipients

              Discover the DDS // excipients from this company

              All Excipients

              read-more
              read-more

              01

              Acesulfame Potassium

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down Click Us! arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 39527

              Submission : 2024-02-08

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              02

              Beta-Cyclodextrin

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 39536

              Submission : 2024-02-14

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              03

              Croscarmellose Sodium

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 37534

              Submission : 2022-09-27

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              04

              Hydroxypropyl Betacyclodextrin

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 23816

              Submission : 2010-05-15

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              05

              Lactose Monohydrate

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 32957

              Submission : 2018-07-18

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              06

              Mannitol

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 41204

              Submission : 2025-01-15

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              07

              Sodium Starch Glycolate

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 37083

              Submission : 2022-04-28

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              08

              Sodium Stearyl Fumarate

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 37309

              Submission : 2022-07-12

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              09

              Sucralose

              India

              USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

              arrow
              CPhI WW Frankfurt
              Booth #8.0Q2
              • fda
              • EDQM
              • WHO-GMP
              Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.
              USDMF arrow-down
              ✖

              GDUFA

              DMF Review : N/A

              Rev. Date :

              Pay. Date :

              DMF Number : 25112

              Submission : 2011-07-08

              Status : Active

              Type : IV

               CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
              Gangwal Healthcare CB

              Product
              Web Link

              Stock Recap
              #PipelineProspector

              Market
              Place

              Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

              KEY EXCIPIENTS

              read-more
              read-more

              TOP RANKED SUPPLIER FOR:

              Gangwal Healthcare full-view
              ProBlend®
              full-view
              Mpressol™
              full-view
              Complexol-HP®
              full-view

              Excipients by Ingredients

              Discover their expertise by components

              Excipients By applications

              Discover their expertise by claims

              ABOUT THIS PAGE

              Contact Gangwal Healthcare and get a quotation

              Gangwal Healthcare is a supplier offers 5 products (APIs, Excipients or Intermediates).

              Find a price of Salmeterol Xinafoate bulk with DMF offered by Gangwal Healthcare

              Find a price of Timolol Maleate bulk offered by Gangwal Healthcare

              Find a price of Formoterol Fumarate bulk offered by Gangwal Healthcare

              Find a price of Modafinil bulk offered by Gangwal Healthcare

              Find a price of Palmitoylethanolamide bulk offered by Gangwal Healthcare

              Ask Us for Pharmaceutical Supplier and Partner
              Ask Us, Find A Supplier / Partner
              No Commissions, No Strings Attached, Get Connected for FREE

              What are you looking for?

              How can we help you?

              The request can't be empty

              Please read our Privacy Policy carefully

              You must agree to the privacy policy

              The name can't be empty
              The company can't be empty.
              The email can't be empty Please enter a valid email.
              The mobile can't be empty

              Market Place

              Market Place

              PharmaCompass

              Home

              Market Place

              Menu

              Post Enquiry

              Post Enquiry

              Market Place

              Market Place

              Search